Atlas Trials

Zhou Fuxiang

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Zhou Fuxiang

RecordFirmDate
Umbilical Cord Blood Derived MAK Immune Cells Combined With Standard Second-Line Treatments for Hepatobiliary and Pancreatic Malignancies (NCT05240690)Zhou Fuxiang2022-02-07
Fruquintinib Combined With mFOLFOX6/FOLFIRI in First-line Treatment for Metastatic Colorectal Cancer (NCT05004441)Zhou Fuxiang2021-07-22
Apatinib Plus Camrelizumab Combined With Docetaxel and S1 in First-line Treatment for Metastatic Gastric Cancer (NCT04781686)Zhou Fuxiang2021-05-14
Preoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer (NCT04801511)Zhou Fuxiang2021-03-08

Track Zhou Fuxiang automatically

Every clearance here is in the API, with alerts when new ones post.